LogicBio Therapeutics Inc (NASDAQ:LOGC)

9.38
Delayed Data
As of Jan 27
 +0.71 / +8.19%
Today’s Change
6.34
Today|||52-Week Range
20.07
+30.28%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for LogicBio Therapeutics Inc have a median target of 22.00, with a high estimate of 26.00 and a low estimate of 18.00. The median estimate represents a +134.54% increase from the last price of 9.38.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in LogicBio Therapeutics Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.49
Sales
$0.00
Reporting Date
Apr 06

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -2.92%
 
 
 
 
 
 
Growthannually 41.78%
 
 
 

Sales

Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.